메뉴 건너뛰기




Volumn 26, Issue 6, 2006, Pages 815-817

Successful use of recombinant factor VIIa (NovoSeven) in children with compartment syndrome: Two case reports

Author keywords

Compartment syndrome; End stage renal disease; Liver failure; Recombinant factor VIIa

Indexed keywords

ANTIBIOTIC AGENT; DESMOPRESSIN; ENOXAPARIN; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

EID: 33750438457     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bpo.0000235399.41913.18     Document Type: Article
Times cited : (7)

References (19)
  • 1
    • 17044377496 scopus 로고    scopus 로고
    • Compartment syndrome in children and adolescents
    • Grottkau BE, Epps HR, Di Scala C. Compartment syndrome in children and adolescents. J Pediatr Surg. 2005;40:678-682.
    • (2005) J Pediatr Surg , vol.40 , pp. 678-682
    • Grottkau, B.E.1    Epps, H.R.2    Di Scala, C.3
  • 2
    • 0034871040 scopus 로고    scopus 로고
    • Acute compartment syndrome in children: Contemporary diagnosis, treatment, and outcome
    • Bae DS, Kadiyala RK, Waters PM. Acute compartment syndrome in children: contemporary diagnosis, treatment, and outcome. J Pediatr Orthop. 2001;21:680-688.
    • (2001) J Pediatr Orthop , vol.21 , pp. 680-688
    • Bae, D.S.1    Kadiyala, R.K.2    Waters, P.M.3
  • 3
    • 0043127159 scopus 로고    scopus 로고
    • Update on Novo Nordisk's clinical trial programme on NovoSeven
    • Dejgaard A. Update on Novo Nordisk's clinical trial programme on NovoSeven. Blood Coagul Fibrinolysis. 2003;14(suppl 1):S39-S41.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , Issue.SUPPL. 1
    • Dejgaard, A.1
  • 4
    • 18044380093 scopus 로고    scopus 로고
    • Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity
    • Watts RG. Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity. Am J Hematol. 2005;79:58-60.
    • (2005) Am J Hematol , vol.79 , pp. 58-60
    • Watts, R.G.1
  • 5
    • 0031743928 scopus 로고    scopus 로고
    • A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia a and B, with and without inhibitors
    • rFVIIa Study Group
    • Lusher JM, Roberts HR, Davignon G, et al. rFVIIa Study Group. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. Haemophilia. 1998;4:790-798.
    • (1998) Haemophilia , vol.4 , pp. 790-798
    • Lusher, J.M.1    Roberts, H.R.2    Davignon, G.3
  • 6
    • 3242709784 scopus 로고    scopus 로고
    • Recombinant activated factor VII for non-hemophiliac bleeding patients
    • Uhlmann EJ, Eby CS. Recombinant activated factor VII for non-hemophiliac bleeding patients. Curr Opin Hematol. 2004;11:198-204.
    • (2004) Curr Opin Hematol , vol.11 , pp. 198-204
    • Uhlmann, E.J.1    Eby, C.S.2
  • 7
    • 31144465054 scopus 로고    scopus 로고
    • Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia
    • Yilmaz BT, Alioglu B, Ozyurek E, et al. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia. Pediatr Cardiol. 2005;26:843-845.
    • (2005) Pediatr Cardiol , vol.26 , pp. 843-845
    • Yilmaz, B.T.1    Alioglu, B.2    Ozyurek, E.3
  • 8
    • 0038519437 scopus 로고    scopus 로고
    • Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin
    • Ng HJ, Koh LP, Lee LH. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin. Ann Hematol. 2003;82:257-258.
    • (2003) Ann Hematol , vol.82 , pp. 257-258
    • Ng, H.J.1    Koh, L.P.2    Lee, L.H.3
  • 9
    • 1542681456 scopus 로고    scopus 로고
    • Recombinant factor VIIa improves coagulopathy caused by liver failure
    • Brown JB, Emerick KM, Brown DL, et al. Recombinant factor VIIa improves coagulopathy caused by liver failure. J Pediatr Gastroenterol Nutr. 2003;37:268-272.
    • (2003) J Pediatr Gastroenterol Nutr , vol.37 , pp. 268-272
    • Brown, J.B.1    Emerick, K.M.2    Brown, D.L.3
  • 10
    • 17844381614 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy
    • Atkison PR, Jardine L, Williams S, et al. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy. Transplant Proc. 2005;37:1091-1093.
    • (2005) Transplant Proc , vol.37 , pp. 1091-1093
    • Atkison, P.R.1    Jardine, L.2    Williams, S.3
  • 11
    • 1542619698 scopus 로고    scopus 로고
    • Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials
    • Caldwell SH, Chang C, Macik BG. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials. Hepatology. 2004;39:592-598.
    • (2004) Hepatology , vol.39 , pp. 592-598
    • Caldwell, S.H.1    Chang, C.2    Macik, B.G.3
  • 12
    • 0141784853 scopus 로고    scopus 로고
    • Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent
    • Dunkley SM, Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology. 2003;8:263-264.
    • (2003) Hematology , vol.8 , pp. 263-264
    • Dunkley, S.M.1    Mackie, F.2
  • 13
    • 0036857320 scopus 로고    scopus 로고
    • Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII
    • Langer H, Strohmaier WL, Probst S. Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII. Anaesthesist. 2002;51:914-917.
    • (2002) Anaesthesist , vol.51 , pp. 914-917
    • Langer, H.1    Strohmaier, W.L.2    Probst, S.3
  • 14
    • 0041624337 scopus 로고    scopus 로고
    • New insights into haemostasis in liver failure
    • Kerr R. New insights into haemostasis in liver failure. Blood Coagul Fibrinolysis. 2003;14(suppl 1):S43-S45.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , Issue.SUPPL. 1
    • Kerr, R.1
  • 15
    • 0036260241 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia
    • Slappendel R, Huvers FC, Benraad B, et al. Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia. Anesthesiology. 2002;96:1525-1527.
    • (2002) Anesthesiology , vol.96 , pp. 1525-1527
    • Slappendel, R.1    Huvers, F.C.2    Benraad, B.3
  • 16
    • 0037612571 scopus 로고    scopus 로고
    • Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients
    • Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth. 2003;15:184-188.
    • (2003) J Clin Anesth , vol.15 , pp. 184-188
    • Dutton, R.P.1    Hess, J.R.2    Scalea, T.M.3
  • 17
    • 0037972713 scopus 로고    scopus 로고
    • Successful treatment of acquired factor VIII deficiency in a child using activated factor VII concentrates: Case report and review of the literature
    • Bruggers CS, Bleak S. Successful treatment of acquired factor VIII deficiency in a child using activated factor VII concentrates: case report and review of the literature. J Pediatr Hematol Oncol. 2003;25:578-580.
    • (2003) J Pediatr Hematol Oncol , vol.25 , pp. 578-580
    • Bruggers, C.S.1    Bleak, S.2
  • 19
    • 30944461398 scopus 로고    scopus 로고
    • Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
    • O'Connell KA, Wood JJ, Wise RP, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;18:293-298.
    • (2006) JAMA , vol.18 , pp. 293-298
    • O'Connell, K.A.1    Wood, J.J.2    Wise, R.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.